ProfileGDS4718 / 237779_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 68% 66% 63% 69% 64% 63% 64% 65% 67% 66% 59% 66% 67% 60% 60% 62% 62% 64% 65% 72% 62% 64% 58% 63% 63% 59% 66% 64% 65% 68% 64% 64% 70% 65% 62% 60% 65% 67% 67% 60% 66% 67% 63% 63% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.705568
GSM549102patient 115, normal, homogenized [OPG study]6.5388866
GSM549104patient 119, normal, homogenized [OPG study]6.3908863
GSM549108patient 138, normal, homogenized [OPG study]6.732169
GSM549119patient 077, normal, homogenized [OPG study]6.4133264
GSM549133patient 032, cancer, homogenized [OPG study]6.3551963
GSM549139patient 042, cancer, homogenized [OPG study]6.4236864
GSM549099patient 107, normal, homogenized [OPG study]6.473665
GSM549109patient 139, normal, homogenized [OPG study]6.5970667
GSM549110patient 046, normal, homogenized [OPG study]6.5194466
GSM549114patient 063, normal, homogenized [OPG study]6.0344259
GSM549122patient 082, normal, homogenized [OPG study]6.5758566
GSM549134patient 033, cancer, homogenized [OPG study]6.6297667
GSM549136patient 036, cancer, homogenized [OPG study]6.0771660
GSM549140patient 044, cancer, homogenized [OPG study]6.1364160
GSM549111patient 047, normal, homogenized [OPG study]6.2388262
GSM549113patient 057, normal, homogenized [OPG study]6.2762362
GSM549132patient 031, cancer, homogenized [OPG study]6.4423864
GSM549137patient 038, cancer, homogenized [OPG study]6.4630565
GSM549142patient 047, cancer, homogenized [OPG study]6.9600472
GSM549100patient 110, normal, homogenized [OPG study]6.211562
GSM549107patient 135, normal, homogenized [OPG study]6.3840164
GSM549115patient 068, normal, homogenized [OPG study]5.980558
GSM549116patient 072, normal, homogenized [OPG study]6.3301363
GSM549120patient 078, normal, homogenized [OPG study]6.3297763
GSM549131patient 030, cancer, homogenized [OPG study]6.0696759
GSM549118patient 074, normal, homogenized [OPG study]6.5562666
GSM549129patient 027, cancer, homogenized [OPG study]6.4322564
GSM549123patient 088, normal, homogenized [OPG study]6.4831365
GSM549124patient 006, cancer, homogenized [OPG study]6.6612368
GSM549126patient 015, cancer, homogenized [OPG study]6.4226964
GSM549128patient 025, cancer, homogenized [OPG study]6.4315764
GSM549103patient 117, normal, homogenized [OPG study]6.804670
GSM549117patient 073, normal, homogenized [OPG study]6.383465
GSM549138patient 041, cancer, homogenized [OPG study]6.2536162
GSM549141patient 045, cancer, homogenized [OPG study]6.1178760
GSM549130patient 028, cancer, homogenized [OPG study]6.4526965
GSM549101patient 111, normal, homogenized [OPG study]6.6895267
GSM549105patient 128, normal, homogenized [OPG study]6.6404767
GSM549106patient 134, normal, homogenized [OPG study]6.1328960
GSM549112patient 048, normal, homogenized [OPG study]6.5537866
GSM549125patient 011, cancer, homogenized [OPG study]6.6569167
GSM549127patient 024, cancer, homogenized [OPG study]6.3629463
GSM549135patient 035, cancer, homogenized [OPG study]6.3122763